| Literature DB >> 11484974 |
M Casali1, M Marcellini, A Casali, T Giuntini, E Galante, C Ferrone.
Abstract
Eigtheen patients affected by metastatic renal cell carcinoma, 16 which were assesable, were treated with 1 g/m2 of Gemcitabine (GCB) on days 1, 8 and 15 of a 28-day treatment cycle up to a maximun of ten cycles. All patients in neoplastic progression were treated with chemo- and immunotherapy (5 FU, IL-2, IFN alpha d 13-cis-retinoic acid.) Out of the 16 assessable patients, 5/16 (31%) showed overall response (ICR, 4 PR), 5 (31%) stable disease (SD) and 6 (38%) progression of disease (PD). Toxicity was limited to WHO grades I only, primarily hematological.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11484974
Source DB: PubMed Journal: J Exp Clin Cancer Res ISSN： 0392-9078